drugset / Trial / NCT01314222
Diabetic Peripheral Neuropathic Pain (DPNP)
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with diabetic peripheral neuropathic pain (DPNP).
Timeline
- Start
- 2011-03
- Primary completion
- 2012-03
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-954561 | Unknown | 40 mg | — |
| Subject | BMS-954561 | Unknown | 80 mg | — |
| Subject | BMS-954561 | Unknown | 150 mg | — |
| Subject | BMS-954561 | Unknown | 300 mg | — |
| Subject | Pregabalin | Small molecule | 100 mg | — |